These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1842231)
21. Haem-arginate plus tin-protoporphyrin for acute hepatic porphyria. Dover SB; Graham A; Fitzsimons E; Moore MR; McColl KE Lancet; 1991 Jul; 338(8761):263. PubMed ID: 1676821 [No Abstract] [Full Text] [Related]
22. Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option? Engelhardt K; Trinka E; Franz G; Unterberger I; Spiegel M; Beer R; Pfausler B; Kampfl A; Schmutzhard E Eur J Neurol; 2004 Oct; 11(10):693-7. PubMed ID: 15469454 [TBL] [Abstract][Full Text] [Related]
24. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. von und zu Fraunberg M; Timonen K; Mustajoki P; Kauppinen R Eur J Hum Genet; 2002 Oct; 10(10):649-57. PubMed ID: 12357337 [TBL] [Abstract][Full Text] [Related]
25. [Acute hepatic porphyria and its neurological syndrome]. Bont A; Steck AJ; Meyer UA Schweiz Med Wochenschr; 1996 Jan; 126(1-2):6-14. PubMed ID: 8571113 [TBL] [Abstract][Full Text] [Related]
26. Heme arginate therapy for beta thalassemia: in vitro versus in vivo effects. Rund D; Fibach E; Goldfarb A; Friedberg A; Rachmilewitz E Acta Haematol; 1998; 100(2):82-4. PubMed ID: 9792937 [TBL] [Abstract][Full Text] [Related]
27. Acute hepatic porphyrias. Detection, prophylaxis and treatment. Kostrzewska E; Gregor A Mater Med Pol; 1996; 28(1):5-7. PubMed ID: 9088118 [TBL] [Abstract][Full Text] [Related]
28. Haem arginate as a treatment for myelodysplastic syndromes. Ruutu T; Volin L; Tenhunen R Br J Haematol; 1987 Apr; 65(4):425-8. PubMed ID: 3580298 [TBL] [Abstract][Full Text] [Related]
30. [Efficacy and tolerability of a new hematin in the treatment of an acute attack of porphyria]. Fontaine B; Bakchine S; Derouesne C; Nordmann Y; Laplane D Presse Med; 1987 Feb; 16(4):177. PubMed ID: 2950457 [No Abstract] [Full Text] [Related]
31. The hepatic porphyrias. Romeo G Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654 [No Abstract] [Full Text] [Related]
34. New treatment for porphyria to be studied. J Psychosoc Nurs Ment Health Serv; 1995 May; 33(5):46. PubMed ID: 7636788 [No Abstract] [Full Text] [Related]
35. Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implications. Litman DA; Correia MA J Pharmacol Exp Ther; 1985 Feb; 232(2):337-45. PubMed ID: 3968635 [TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of comprehensive treatment with Normosang and plasmapheresis in acute intermittent porphyria]. Idel'son LI; Aziz GA; Vasil'ev SA; Goncharova NB Gematol Transfuziol; 1992; 37(11-12):15-7. PubMed ID: 1295775 [No Abstract] [Full Text] [Related]
37. Heme in the treatment of heme deficiency states. Tenhunen R Scand J Clin Lab Invest Suppl; 1990; 201():63-75. PubMed ID: 2244185 [TBL] [Abstract][Full Text] [Related]
38. Acute porphyrias: a German monocentric study of the biochemical, molecular genetic, and clinical data of 62 families. Bronisch O; Stauch T; Haverkamp T; Beykirch MK; Petrides PE Ann Hematol; 2019 Dec; 98(12):2683-2691. PubMed ID: 31745600 [TBL] [Abstract][Full Text] [Related]
39. [Trimethoprim in the therapy of symptomatic liver porphyria]. Kaláb M; Kotal P; Jirsa M; Petrtýl J; Vrana J Cas Lek Cesk; 1993 Aug; 132(16):502-6. PubMed ID: 8402817 [TBL] [Abstract][Full Text] [Related]
40. [A new drug for porphyria]. Tenhunen R Nord Med; 1986; 101(4):132-3. PubMed ID: 3737395 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]